Moreover, quite a few properly set up adverse prognostic markers, which includes U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their negative outcome in individuals dealt with with VO. The one aspect that remained predictive of the shorter development-free of charge survival In this particular cohort of patients was TP53 aberrations.1